Dr. Dimopoulos obtained his medical degree from the University of Athens and subsequently completed graduate studies and a research fellowship in Ocular Genetics at the University of Alberta. He was directly involved and lead the outcome measure assessment for an ocular gene therapy trial for choroideremia - the first in Canada. Following his ophthalmology residency training at the University of Ottawa, he completed a 2 -year fellowship in Medical Retina & Ophthalmic Genetics at the National Eye Institute / National Institutes of Health. He recently joined the University of Ottawa's Department of Ophthalmology as an Assistant Professor. His clinical and research interests include inherited retinal disorders, gene therapy, AMD, CSCR, and diabetic retinopathy.

Financial disclosure: Dr. Dimopoulos has/had no affiliation (financial or otherwise) with a commercial organization.